Cargando…

Serum matrix metalloproteinase-13 as a diagnostic biomarker for cutaneous squamous cell carcinoma

BACKGROUND: A significant proportion of newly diagnosed patients with cutaneous squamous cell carcinoma (cSCC) have metastasis and eventually die of the disease, necessitating the exploration of novel biomarkers for early detection of cSCC aggressiveness, risk assessment and monitoring. Matrix metal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hui, Li, Hong, Yan, Qingtao, Gao, Sumei, Gao, Jianfang, Wang, Zhenhua, Sun, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284021/ https://www.ncbi.nlm.nih.gov/pubmed/34266392 http://dx.doi.org/10.1186/s12885-021-08566-1

Ejemplares similares

Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers
por: Cai, Meijuan, et al.
Publicado: (2022)

Estimation of serum matrix metalloproteinases among patients of oral squamous cell carcinoma
por: Choudhry, Nakhshab, et al.
Publicado: (2019)

Diagnostic Accuracy of Serum Matrix Metalloproteinase‐7 for Biliary Atresia
por: Yang, Li, et al.
Publicado: (2018)

Serum Matrix Metalloproteinase 7 as a Diagnostic and Prognostic Biomarker for Extrahepatic Biliary Atresia
por: Singh, Teg Rabab, et al.
Publicado: (2022)

Potential Value of Matrix Metalloproteinase-13 as a Biomarker for Osteoarthritis
por: Xin, Xing, et al.
Publicado: (2021)

Role of matrix metalloproteinase 13 gene expression in the evaluation of radiation response in oral squamous cell carcinoma
por: Singh, Shankar Sharan, et al.
Publicado: (2017)

Plasma Matrix Metalloproteinase-1 as a Prognostic Biomarker in Oral Cavity Squamous Cell Carcinoma
por: Tsai, Tsung-You, et al.
Publicado: (2022)

Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma
por: Matulka, Marlena, et al.
Publicado: (2019)

Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma
por: Mukherjee, Sumana, et al.
Publicado: (2010)

Prognostic value of matrix metalloproteinases in oral squamous cell carcinoma
por: Mishev, Georgi, et al.
Publicado: (2014)

Expression of Matrix Metalloproteinase-21 in Oral Squamous Cell Carcinoma
por: Baskaran, Adhithya, et al.
Publicado: (2023)

Correlation Between the Expression of Matrix Metalloproteinase-9, Matrix Metalloproteinase-13, Tissue Inhibitor of Metalloproteinases-1, p16 and Differentiation of Head and Neck Squamous Cell Carcinoma: A Prospective Observational Study
por: Soni, Kapil, et al.
Publicado: (2021)

Fluctuating Roles of Matrix Metalloproteinase-9 in Oral Squamous Cell Carcinoma
por: Vilen, Suvi-Tuuli, et al.
Publicado: (2013)

Matrix metalloproteinase 13‐containing exosomes promote nasopharyngeal carcinoma metastasis
por: You, Yiwen, et al.
Publicado: (2015)

Serum Matrix Metalloproteinase 7 Is a Diagnostic Biomarker of Biliary Injury and Fibrosis in Pediatric Autoimmune Liver Disease
por: Lam, Simon, et al.
Publicado: (2020)

Combination of serum matrix metalloproteinase-3 activity and EBV antibodies improves the diagnostic performance of nasopharyngeal carcinoma
por: Li, Yiqiu, et al.
Publicado: (2020)

Matrix Metalloproteinase 1, 3, and 9 Polymorphisms and Esophageal Squamous Cell Carcinoma Risk
por: Guan, Xuan, et al.
Publicado: (2014)

Prognostic value of tissue inhibitor of metalloproteinase-matrix metalloproteinase biomarkers at 30 days in patients with acute myocardial infarction without reperfusion therapy
por: Pang, Hui-Fang, et al.
Publicado: (2021)

Lower Serum Matrix Metalloproteinase‑9 in Metastatic Patients with Esophageal Squamous Cell Carcinoma After Concurrent Radiotherapy Was Significant for Prognosis
por: Ye, Ziqi, et al.
Publicado: (2020)

Matrix metalloproteinase‐13 unlucky for the forming thrombus
por: Montague, Samantha J., et al.
Publicado: (2018)

Expression of collagenases (matrix metalloproteinase-1, -8, -13) and tissue inhibitor of metalloproteinase-3 (TIMP-3) in naturally occurring bovine cutaneous fibropapillomas
por: Daraban Bocaneti, Florentina, et al.
Publicado: (2023)

Matrix metalloproteinases (MMPs) and inhibitor of metalloproteinases (TIMP) mRNA and protein expression in laryngeal squamous cell carcinoma
por: Grzelczyk, Weronika Lucas, et al.
Publicado: (2019)

Expression of Matrix Metalloproteinases and Their Inhibitors in Squamous Cell Carcinoma of the Tonsil and Their Clinical Significance
por: Lee, Sei Young, et al.
Publicado: (2011)

The disintegrin-metalloproteinases ADAM10 and ADAM17 are upregulated in cutaneous squamous cell carcinomas
por: Oh, S.-T., et al.
Publicado: (2016)

Expression and prognostic relevance of Cyclophilin A and matrix metalloproteinase 9 in esophageal squamous cell carcinoma
por: Li, Yi, et al.
Publicado: (2013)

Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer
por: El Demery, Mounira, et al.
Publicado: (2014)

Evaluation of Matrix Metalloproteinase 9 Serum Concentration as a Biomarker in Malignant Mesothelioma
por: Štrbac, Danijela, et al.
Publicado: (2019)

Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma
por: Wang, Wenjian, et al.
Publicado: (2017)

Matrix metalloproteinases in keratinocyte carcinomas
por: Riihilä, Pilvi, et al.
Publicado: (2020)

Prediction of metastasis in oral squamous cell carcinoma through phenotypic evaluation and gene expression of E-cadherin, β-catenin, matrix metalloproteinase-2, and matrix metalloproteinase-9 biomarkers with clinical correlation
por: Sowmya, S. V., et al.
Publicado: (2020)

Up-Regulation of Cyclooxygenase 2 and Matrix Metalloproteinases-2 and -9 in Cutaneous Squamous Cell Carcinoma: Active Role of Inflammation and Tissue Remodeling in Carcinogenesis
por: Lee, Jeong-Hoon, et al.
Publicado: (2013)

Evaluation of the Expression of Matrix Metalloproteinase-1 of Laryngeal Squamous Cell Carcinoma by Ultrasound Molecular Imaging
por: Zhou, Yi, et al.
Publicado: (2019)

Serum Matrix Metalloproteinase-3 as a Noninvasive Biomarker of Histological Synovitis for Diagnosis of Rheumatoid Arthritis
por: Ma, Jian-Da, et al.
Publicado: (2014)

Loss of BAX by miR-365 Promotes Cutaneous Squamous Cell Carcinoma Progression by Suppressing Apoptosis
por: Zhou, Liang, et al.
Publicado: (2017)

Estimation of serum and salivary matrix metalloproteinase levels in oral squamous cell carcinoma patients: a systematic review and meta-analysis
por: Rezaei, Farzad, et al.
Publicado: (2021)

Evaluation of Serum Levels of Matrix MetalloProteinase-9 (MMP-9) in Oral Squamous Cell Carcinoma and Its Clinicopathological Correlation
por: Benitha, Georgia, et al.
Publicado: (2023)

The expression and clinical significance of matrix metalloproteinase 7 and tissue inhibitor of matrix metalloproteinases 2 in clear cell renal cell carcinoma
por: LU, HONGSHENG, et al.
Publicado: (2013)

Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis
por: Tsukifuji, R, et al.
Publicado: (1999)

Relationship between the Expression of Matrix Metalloproteinase and Clinicopathologic Features in Oral Squamous Cell Carcinoma
por: Jafarian, Amir Hossein, et al.
Publicado: (2015)

Differential expression of matrix metalloproteinases and miRNAs in the metastasis of oral squamous cell carcinoma
por: Ren, Zhen-Hu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5c0n573aimsp0judl19p1ap83c